October 07, 2024

Tricounty Behavioral Health Highlights Success of FDA-Approved TMS Therapy for Treatment of Depression in North Charleston

Grand News Network | September 2, 2024

FDA-Approved TMS Therapy for Depression has been a game-changer for the past 5 years at Tricounty Behavioral Health in North Charleston, SC

United States, 2nd Sep 2024 Tricounty Behavioral Health is proud to highlight the continued success of Transcranial Magnetic Stimulation (TMS) at our North Charleston clinic. For the past five years, we have been offering this cutting-edge, FDA-approved treatment, providing new hope to individuals battling depression, particularly those who have not found relief with traditional antidepressant medications.

Tricounty Behavioral Health Highlights Success of FDA-Approved TMS Therapy for Treatment of Depression in North Charleston

TMS is a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation. Unlike medications that affect the entire body, TMS directly targets the brain’s mood-regulating regions, offering a highly focused approach that addresses the root of depression with minimal side effects. Patients can resume their daily activities immediately after each session, making TMS a convenient option for those with busy schedules.

“With five years of experience providing TMS, we have seen firsthand the profound transformative benefits it has had on our patients’ lives,” said Dr. Pascale Mardikian, co-owner of Tricounty Behavioral Health. According to Dr. Mari Asper, also co-owner, “Depression can be a challenging condition, and for many, traditional treatments have not been enough. TMS offers an alternative pathway to wellness, especially for those who have struggled with the side effects or ineffectiveness of antidepressants.”

TMS is particularly effective for individuals diagnosed with Major Depressive Disorder (MDD) who have not responded to antidepressant medications. Clinical studies and our own extensive experience have shown that TMS can significantly reduce symptoms of depression and, in some cases, lead to complete remission. A typical treatment course involves 36 daily sessions, each lasting 10-15 minutes, over several weeks.

Tricounty Behavioral Health Highlights Success of FDA-Approved TMS Therapy for Treatment of Depression in North Charleston

In 2019, the Charleston psychiatry doctors became certified in TMS Therapy for treatment-resistant depression under the guidance of Dr. Mark George at the Medical University of South Carolina.

TMS is covered by most insurance plans, including Medicare, making it an accessible option for a broad range of patients. At Tricounty Behavioral Health, we are committed to providing high-quality, evidence-based treatments, and we believe that TMS will continue to make a profound difference in the lives of our patients.

For more information about TMS or to schedule a consultation, please visit our website at www.tricountybehavioral.com or call Tricounty Behavioral Health at 843-377-1600.

About Tricounty Behavioral Health:

Since 2004, Tricounty Behavioral Health has been a leading mental health provider in North Charleston, SC. Our team of experienced psychiatry professionals is dedicated to providing compassionate, personalized treatment plans to help our patients overcome mental health challenges and achieve lasting wellness.

Media Contact

Organization: Tricounty Behavioral Health

Contact Person: Dr. Mari Asper, Psychiatrist

Website: https://tricountybehavioral.com

Email: Send Email

Country:United States

Release id:16465

The post Tricounty Behavioral Health Highlights Success of FDA-Approved TMS Therapy for Treatment of Depression in North Charleston appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

file

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner